Press release
Dysmenorrhea Market Expected to Experience Major Growth by 2034, According to DelveInsight | ObsEva SA, Fuji Pharma's, Bayer, Juniper Pharmaceuticals, Inc., Nobelpharma, AbbVie, GlaxoSmithKline
The Key Dysmenorrhea Companies in the market include - ObsEva SA, Fuji Pharma's, Bayer, Juniper Pharmaceuticals, Inc., Nobelpharma, Laboratorios Andromaco S.A., Boehringer Ingelheim, Organon and Co, Pfizer, Duramed Research, Vantia Ltd, Lianyungang Kanion Group, Ltd., Jiangsu Kanion Pharmaceutical Co, Isifer AB, AbbVie, GlaxoSmithKline, and others.DelveInsight's "Dysmenorrhea Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Dysmenorrhea, historical and forecasted epidemiology as well as the Dysmenorrhea market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Dysmenorrhea market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Dysmenorrhea Market Forecast [https://www.delveinsight.com/report-store/dyslipidemia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Dysmenorrhea Market Report:
*
The Dysmenorrhea market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In May 2024, TiumBio Co., Ltd. (KOSDAQ: 321550), a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for rare and incurable diseases, announced positive topline results from its Phase 2a clinical trial of Merigolix. This oral gonadotropin-releasing hormone (GnRH) receptor antagonist was tested in patients with moderate to severe endometriosis-associated pain. The trial successfully met its primary endpoint, showing a statistically significant reduction in dysmenorrhea scores compared to placebo across all three dosage groups (120mg p=0.044, 240mg p=0.001, 320mg p
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dysmenorrhea Market Expected to Experience Major Growth by 2034, According to DelveInsight | ObsEva SA, Fuji Pharma's, Bayer, Juniper Pharmaceuticals, Inc., Nobelpharma, AbbVie, GlaxoSmithKline here
News-ID: 3798279 • Views: …
More Releases from ABNewswire
How Ontario Therapy in Newmarket is Helping Clients Overcome Trauma with Proven …
Ontario Therapy in Newmarket helps clients overcome trauma with proven techniques, offering personalized support for lasting healing and recovery.
Newmarket, ON - Ontario Therapy, a leading provider of trauma therapy in Newmarket, is committed to helping individuals heal from the effects of trauma using proven therapeutic techniques. The clinic's personalized approach focuses on providing tailored care to meet each client's specific needs, helping them achieve emotional well-being and take steps toward…
Attorney Big Al California Offers Top Legal Advice for Car Accident Claims in Ea …
Attorney Big Al in California offers expert legal advice for car accident claims in East Hemet, helping victims get the compensation they deserve.
Sherman Oaks, CA - Attorney Big Al California, a trusted name in personal injury law, is proud to offer expert legal services to residents of East Hemet and the surrounding areas. Specializing in car accident claims, the firm provides compassionate, results-driven legal representation to individuals seeking justice after…
Magical Moments ABA's In-Home Therapy Approach: Personalized Care for Every Chil …
Magical Moments ABA offers personalized in-home therapy tailored to each child's needs, providing effective care for children with autism in a comfortable setting.
Marietta, GA - Magical Moments ABA is excited to introduce its unique in-home therapy approach, designed to provide personalized care for children with autism and developmental delays. This therapy model focuses on developing individualized treatment plans that address each child's unique needs, ensuring they receive the best support…
Gras Lawn's Expert Commercial Snow Removal Solutions Ensure Safety in West Hartf …
Gras Lawn offers expert commercial snow removal services in West Hartford, CT, ensuring safety and accessibility during winter months.
West Hartford, CT - As winter weather approaches, Gras Lawn, a trusted provider of commercial landscaping and snow management services, is once again offering its professional commercial snow removal West Hartford CT [https://graslawn.com/commercial-snow-and-ice-management-west-hartford-ct/]. The company's commitment to safety and efficiency has made it a go-to partner for commercial snow removal, ensuring that…
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Global Dysmenorrhea Market report from Global Insight Services is the single authoritative source of intelligence on Dysmenorrhea market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
